Gillette minus Rembrandt
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble is granted conditional approval of its proposed acquisition of Gillette by FTC, "provided the companies divest a variety of overlapping assets," including the Rembrandt at-home teeth whitening business, the commission announces Sept. 30. FTC also calls on P&G to sell Right Guard men's antiperspirant and deodorant business to avoid suppressing competition in those market sectors. P&G said in September it would sell the Crest SpinBrush business under a requirement by the European Commission (1"The Tan Sheet" Sept. 19, 2005, In Brief)...
You may also be interested in...
Dial Expands Personal Care Portfolio With Gillette Antiperspirant Buy
Dial will enter the antiperspirants/deodorants category with the purchase of the Right Guard, Soft & Dri and Dry Idea brands from Gillette, the Henkel division announced Feb 20
P&G merger
Procter & Gamble will sell its SpinBrush power toothbrush division to Church & Dwight as part of the regulatory approval process with the European Commission in the firm's $57 bil. merger with Gillette, P&G announced Sept. 14. The sale will cost Church & Dwight $75 mil. in cash at closing, plus an inventory settlement amount, and up to $30 mil. in cash based on near-term performance, the firm says. The sale, required by European regulators due to brand overlaps with Gillette's Oral-B line, is subject to approval by U.S. and European authorities and is expected to close in the fourth quarter 2005 ("1The Tan Sheet" July 18, 2005, In Brief). P&G is in "ongoing discussions with the FTC and expects this divestiture will move the Gillette merger one step closer to completion of the FTC clearance process," the firm reports...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.